Topic-Contributed Paper Session
Statistics and Data Science in Pharmaceutical Drug Development and Healthcare
Elena PolverejanOrganizerAkiko OkamotoChair
Section on Statistical Consulting
4 Presentations
10:35 AM - 10:55 AM
Todd Sanger (Eli Lilly and Company)
10:55 AM - 11:15 AM
Charmaine Demanuele Nayak (Pfizer)
11:15 AM - 11:35 AM
David Ohlssen (Novartis Pharmaceuticals)
11:35 AM - 11:55 AM
Stephen Ruberg (Analytix Thinking, LLC)
Discussant
Sue-Jane Wang (FDA/Office of Biostatistics, Office of Translational Sciences, CDER)